default author photo

Yuehong Cui

Fudan University, Zhongshan Hospital, Department of Oncology

China

SCHOLARLY PAPERS

2

DOWNLOADS

120

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Bevacizumab Plus Chemotherapy versus Chemotherapy Alone As First-Line Treatment for Patients with RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Single Center Randomized Control Trial

Number of pages: 43 Posted: 29 Dec 2019
Fudan University - Department of General Surgery, Fudan University - Department of General Surgery, Fudan University - Department of Liver Surgery and Transplantation, Fudan University - Department of General Surgery, Fudan University - Department of General Surgery, Fudan University - Department of General Surgery, Fudan University - Department of Liver Surgery and Transplantation, Fudan University - Department of Radiology, Fudan University, Zhongshan Hospital, Department of Oncology, Fudan University, Zhongshan Hospital, Department of Oncology and Fudan University - Colorectal Cancer Center
Downloads 77 (823,616)

Abstract:

Loading...

Bevacizumab; RAS mutant; unresectable; colorectal liver-limited metastases

2.

Identification of Key Genes Involved in Tumor Immune Infiltration and Cetuximab Resistance in Colorectal Cancer

Number of pages: 45 Posted: 11 Nov 2020
Department of Medical Oncology, Zhongshan Hospital, Fudan University, Department of Medical Oncology, Zhongshan Hospital, Fudan University, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Department of Medical Oncology, Zhongshan Hospital, Fudan University, Fudan University - Department of Oncology, Fudan University, Zhongshan Hospital, Department of Oncology, Fudan University - Department of Gastroenterology and Fudan University - Department of Medical Oncology
Downloads 43 (1,145,425)

Abstract:

Loading...

colorectal cancer, drug resistance, anti-epidermal growth factor receptor therapy, tumor immune infiltration, transcriptional alterations